Scandinavian Breast Group

The Scandinavian Breast Group (SBG) is a prominent academic clinical research organization and collaborative network focused on advancing the treatment and understanding of breast cancer. Founded in 1981, the group coordinates multicenter clinical trials across Sweden, Norway, Denmark, Finland, and Iceland. SBG's research primarily focuses on optimizing systemic therapies, including chemotherapy, endocrine therapy, and targeted agents, through large-scale Phase II and Phase III trials. The organization plays a critical role in establishing clinical guidelines and improving patient outcomes in the Nordic region and internationally. It operates as a non-profit entity, often in close collaboration with major Nordic university hospitals and the Karolinska Institutet.